MedTrace Logo

Clinical Trials

NCT01856192 | ACTIVE_NOT_RECRUITING | PHASE2
349 participants

Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2013-08-27
Completion:
2020-03-26
Conditions
  • Ann Arbor Stage II Diffuse Large B-Cell Lymphoma
  • Ann Arbor Stage III Diffuse Large B-Cell Lymphoma
  • Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma
Interventions
  • DRUG
  • OTHER
  • BIOLOGICAL
Results Available
NCT01841736 | ACTIVE_NOT_RECRUITING | PHASE2
171 participants

Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2013-09-20
Completion:
2019-03-05
Conditions
  • Foregut Neuroendocrine Tumor
  • Hindgut Neuroendocrine Tumor
  • Metastatic Digestive System Neuroendocrine Tumor G1
  • Metastatic Neuroendocrine Tumor
  • Midgut Neuroendocrine Tumor G1
  • Neuroendocrine Tumor G2
  • Recurrent Digestive System Neuroendocrine Tumor G1
  • Regional Digestive System Neuroendocrine Tumor G1
Interventions
  • OTHER
  • PROCEDURE
  • DRUG
Results Available
NCT01810913 | RECRUITING | PHASE2/PHASE3
613 participants

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2013-03-22
Completion:
2027-01-01
Conditions
  • Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma
  • Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
  • Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7
  • Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
  • Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7
  • Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7
  • Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7
  • Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
  • Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7
Interventions
  • DRUG
  • PROCEDURE
  • BIOLOGICAL
  • RADIATION
  • OTHER
No Results Yet
NCT01708941 | ACTIVE_NOT_RECRUITING | PHASE2
88 participants

Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2013-01-18
Completion:
2017-08-08
Conditions
  • Recurrent Melanoma
  • Stage IIIA Cutaneous Melanoma AJCC v7
  • Stage IIIB Cutaneous Melanoma AJCC v7
  • Stage IIIC Cutaneous Melanoma AJCC v7
  • Stage IV Cutaneous Melanoma AJCC v6 and v7
Interventions
  • BIOLOGICAL
  • OTHER
Results Available
NCT01522976 | ACTIVE_NOT_RECRUITING | PHASE2
282 participants

Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2012-03-01
Completion:
2015-06-01
Conditions
  • Chronic Myelomonocytic Leukemia
  • Chronic Myelomonocytic Leukemia-1
  • Chronic Myelomonocytic Leukemia-2
  • Myelodysplastic Syndrome
  • Myelodysplastic Syndrome With Excess Blasts
  • Myelodysplastic Syndrome With Excess Blasts-1
  • Myelodysplastic Syndrome/Acute Myeloid Leukemia
Interventions
  • DRUG
  • OTHER
Results Available
NCT01274338 | ACTIVE_NOT_RECRUITING | PHASE3
1673 participants

Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2011-06-17
Completion:
2019-02-15
Conditions
  • Melanoma of Unknown Primary
  • Recurrent Melanoma
  • Stage IIIB Cutaneous Melanoma AJCC v7
  • Stage IIIC Cutaneous Melanoma AJCC v7
  • Stage IV Cutaneous Melanoma AJCC v6 and v7
Interventions
  • BIOLOGICAL
  • OTHER
Results Available
NCT01272037 | ACTIVE_NOT_RECRUITING | PHASE3
5018 participants

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2011-02-28
Completion:
2023-02-01
Conditions
  • Breast Ductal Carcinoma In Situ
  • Invasive Breast Carcinoma
  • Multicentric Breast Carcinoma
  • Multifocal Breast Carcinoma
  • Synchronous Bilateral Breast Carcinoma
Interventions
  • DRUG
  • OTHER
Results Available
NCT01174108 | RECRUITING | PHASE2
120 participants

Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2010-12-10
Completion:
2027-12-30
Conditions
  • Severe Aplastic Anemia
  • MDS (Myelodysplastic Syndrome)
Interventions
  • DEVICE
  • OTHER
No Results Yet
NCT01170793 | COMPLETED | NA
88 participants

Medicine Abuse Headache

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2010-08-31
Completion:
2012-06-30
Conditions
  • Migraine
Interventions
  • BEHAVIORAL
No Results Yet
NCT01167712 | ACTIVE_NOT_RECRUITING | PHASE3
692 participants

Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2010-09-27
Completion:
2015-12-01
Conditions
  • Fallopian Tube Endometrioid Adenocarcinoma
  • Fallopian Tube Mucinous Adenocarcinoma
  • Fallopian Tube Transitional Cell Carcinoma
  • Ovarian Brenner Tumor
  • Ovarian Clear Cell Adenocarcinofibroma
  • Ovarian Endometrioid Adenocarcinoma
  • Ovarian Mucinous Adenocarcinoma
  • Ovarian Seromucinous Carcinoma
  • Ovarian Serous Adenocarcinoma
  • Ovarian Transitional Cell Carcinoma
  • Ovarian Undifferentiated Carcinoma
  • Primary Peritoneal Serous Adenocarcinoma
  • Stage IIA Fallopian Tube Cancer AJCC v6 and v7
  • Stage IIA Ovarian Cancer AJCC V6 and v7
  • Stage IIB Fallopian Tube Cancer AJCC v6 and v7
  • Stage IIB Ovarian Cancer AJCC v6 and v7
  • Stage IIC Fallopian Tube Cancer AJCC v6 and v7
  • Stage IIC Ovarian Cancer AJCC v6 and v7
  • Stage IIIA Fallopian Tube Cancer AJCC v7
  • Stage IIIA Ovarian Cancer AJCC v6 and v7
  • Stage IIIA Primary Peritoneal Cancer AJCC v7
  • Stage IIIB Fallopian Tube Cancer AJCC v7
  • Stage IIIB Ovarian Cancer AJCC v6 and v7
  • Stage IIIB Primary Peritoneal Cancer AJCC v7
  • Stage IIIC Fallopian Tube Cancer AJCC v7
  • Stage IIIC Ovarian Cancer AJCC v6 and v7
  • Stage IIIC Primary Peritoneal Cancer AJCC v7
  • Stage IV Fallopian Tube Cancer AJCC v6 and v7
  • Stage IV Ovarian Cancer AJCC v6 and v7
  • Stage IV Primary Peritoneal Cancer AJCC v7
Interventions
  • BIOLOGICAL
  • DRUG
  • PROCEDURE
Results Available
NCT01142388 | ACTIVE_NOT_RECRUITING | PHASE2
94 participants

Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2010-09-21
Completion:
2014-07-15
Conditions
  • Metastatic Esophageal Adenocarcinoma
  • Metastatic Esophageal Squamous Cell Carcinoma
  • Metastatic Gastroesophageal Junction Adenocarcinoma
  • Recurrent Esophageal Adenocarcinoma
  • Recurrent Esophageal Carcinoma
  • Recurrent Esophageal Squamous Cell Carcinoma
  • Recurrent Gastroesophageal Junction Adenocarcinoma
  • Stage IV Esophageal Cancer AJCC v7
Interventions
  • BIOLOGICAL
  • OTHER
  • DRUG
Results Available
NCT01134614 | ACTIVE_NOT_RECRUITING | PHASE2
245 participants

Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2010-12-28
Completion:
2013-02-15
Conditions
  • Advanced Melanoma
  • Metastatic Melanoma
  • Recurrent Melanoma
  • Stage III Cutaneous Melanoma AJCC v7
  • Stage IIIA Cutaneous Melanoma AJCC v7
  • Stage IIIB Cutaneous Melanoma AJCC v7
  • Stage IIIC Cutaneous Melanoma AJCC v7
  • Stage IV Cutaneous Melanoma AJCC v6 and v7
  • Unresectable Melanoma
Interventions
  • BIOLOGICAL
Results Available
Previous
Sorted by latest updates
Next
Showing 40 trials per page